The China-based cancer diagnostic firm, AnPac Bio-Medial Science Co. Ltd. (ANPC) while rallying over its success with the Nasdaq market value requirement, is not out
AnPac Bio-Medical Science Co., Ltd. (ANPC) is a late-stage biopharmaceutical company engaged in the development of early cancer detection. The company has two authorized clinical
As the U.S. reached 300,000 deaths connected with Covid-19, the first shots were given. The nurse in New York City was first vaccinated against COVID-19.
AnPac Bio-Medical Science Co. Ltd. (ANPC) stock plunged 0.0% to $7.14 in the pre-market trading after announcing that it experienced strong demand for its cancer
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.